PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Rheumatology, Department of Medicine, University of Perugia, Piazzale Giorgio Menghini, 1, 06129, Perugia, Italy.\', \'Rheumatology, Allergology and Clinical Immunology, Department of \'Medicina dei Sistemi\', University of Rome Tor Vergata, Via Montpellier 1, 00133, Rome, Italy.\', \'Rheumatology, Department of Medicine, University of Perugia, Piazzale Giorgio Menghini, 1, 06129, Perugia, Italy. Electronic address: roberto.gerli@unipg.it.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0896-8411(20)30084-610.1016/j.jaut.2020.102468
?:hasPublicationType
?:journal
  • Journal of autoimmunity
is ?:pmid of
?:pmid
?:pmid
  • 32317220
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.046
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all